المؤلفون: Vojdeman, FJ, Herman, SEM, Kirkby, N, Wiestner, A, van t' Veer, MB, Tjonnfjord, GE, Itala-Remesg, MA, Kimby, E, Farooqui, MZ, Polliack, A, Wu, KL, Doorduijn, JK, Alemayehu, WG, Wittebol, S, Kozak, T, Walewski, J, Abrahamse-Testroote, MCJ, Van Oers, MHJ, Geisler, CH, Niemann, CU

المصدر: Leukemia & lymphoma. 58(10):2356-2362

مصطلحات موضوعية: Medicin och hälsovetenskap

الوصول الحر: http://kipublications.ki.se/Default.aspx?queryparsed=id:136136957Test

المؤلفون: Jurczyszyn, A, Grzasko, N, Gozzetti, A, Czepiel, J, Cerase, A, Hungria, V, Crusoe, E, Dias, ALMS, Vij, R, Fiala, MA, Caers, J, Rasche, L, Nooka, AK, Lonial, S, Vesole, DH, Philip, S, Gangatharan, S, Druzd-Sitek, A, Walewski, J, Corso, A, Cocito, F, Vekemans, MCM, Atilla, E, Beksac, M, Leleu, X, Davila, J, Badros, A, Aneja, E, Abildgaard, N, Kastritis, E, Fantl, D, Schutz, N, Pika, T, Butrym, A, Olszewska-Szopa, M, Usnarska-Zubkiewicz, L, Usmani, SZ, Nahi, H, Chim, CS, Shustik, C, Madry, K, Lentzsch, S, Swiderska, A, Helbig, G, Guzicka-Kazimierczak, R, Lendvai, N, Waage, A, Andersen, KT, Murakami, H, Zweegman, S, Castillo, JJ

المصدر: American journal of hematology. 91(6):575-580

مصطلحات موضوعية: Medicin och hälsovetenskap

الوصول الحر: http://kipublications.ki.se/Default.aspx?queryparsed=id:133734097Test

المؤلفون: Zinzani P. L., Trneny M., Ribrag V., Zilioli V. R., Walewski J., Christensen J. H., Delwail V., Rodriguez G., Venugopal P., Coleman M., Dartigeas C., Patti C., Pane F., Jurczak W., Taszner M., Paneesha S., Zheng F., DeMarini D. J., Jiang W., Gilmartin A., Mehta A.

المساهمون: Zinzani P.L., Trneny M., Ribrag V., Zilioli V.R., Walewski J., Christensen J.H., Delwail V., Rodriguez G., Venugopal P., Coleman M., Dartigeas C., Patti C., Pane F., Jurczak W., Taszner M., Paneesha S., Zheng F., DeMarini D.J., Jiang W., Gilmartin A., Mehta A.

مصطلحات موضوعية: B-cell lymphoma, Mantle cell lymphoma, Non-Hodgkin lymphoma, Parsaclisib, PI3K inhibitor

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37599908; volume:62; firstpage:1; lastpage:12; numberofpages:12; journal:ECLINICALMEDICINE; https://hdl.handle.net/11585/960110Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85167781951; https://www.sciencedirect.com/science/article/pii/S2589537023003085?via=ihubTest

الإتاحة: https://doi.org/10.1016Test/j.eclinm.2023.102131
https://hdl.handle.net/11585/960110Test
https://www.sciencedirect.com/science/article/pii/S2589537023003085?via=ihubTest

المؤلفون: Ghielmini, M, Vitolo, U, Kimby, E, Montoto, S, Walewski, J, Pfreundschuh, M, Federico, M, Hoskin, P, McNamara, C, Caligaris-Cappio, F, Stilgenbauer, S, Marcus, R, Trneny, M, Dreger, P, Montserrat, E, Dreyling, M

المصدر: Annals of oncology : official journal of the European Society for Medical Oncology. 24(3):561-576

مصطلحات موضوعية: Medicin och hälsovetenskap

الوصول الحر: http://kipublications.ki.se/Default.aspx?queryparsed=id:126397151Test

المؤلفون: Dytfeld, D., Wróbel, T., Jamroziak, K., Kubicki, T., Robak, P., Walter-Croneck, A., Czyż, J., Tyczyńska, A., Druzd-Sitek, A., Giannopoulos, K., Nowicki, A., Szczepaniak, T., Łojko-Dankowska, A., Matuszak, M., Gil, L., Puła, B., Rybka, J., Majcherek, M., Usnarska-Zubkiewicz, L., Szukalski, L., Końska, A., Zaucha, J. M., Walewski, J., Mikulski, D., Czabak, O., Robak, T., Grzybowska, U., Lahoud, O. B., Zonder, J. A., Griffith, K., Stefka, A., Major, A., Derman, B. A., Jakubowiak, A. J.

المصدر: HemaSphere ; volume 6, page 76-77 ; ISSN 2572-9241

الإتاحة: https://doi.org/10.1097/01.hs9.0000843592.63620.b4Test

المؤلفون: Wang, M. L., Jurczak, W., Jerkeman, M., Trotman, J., Zinani, P. L., Belada, D., Boccomini, C., Flinn, I. W., Giri, P., Goy, A., Hamlin, P. A., Hermine, O., Hernández-Rivas, J.-Á., Hong, X., Kim, S. J., Lewis, D., Mishima, Y., Özcan, M., Perini, G. F., Pocock, C., Song, Y., Spurgeon, S. E., Storring, J. M., Walewski, J., Zhu, J., Qin, R., Henninger, T., Deshpande, S., Howes, A., Le Gouill, S., Dreyling, M.

المصدر: HemaSphere ; volume 6, page 110-111 ; ISSN 2572-9241

الإتاحة: https://doi.org/10.1097/01.hs9.0000843728.37710.5fTest

المؤلفون: Kim Y. H., Prince H. M., Whittaker S., Horwitz S. M., Duvic M., Bechter O., Sanches J. A., Stadler R., Scarisbrick J., Quaglino P., Zinzani P. L., Wolter P., Eradat H., Pinter-Brown L. C., Ortiz-Romero P. L., Akilov O. E., Trotman J., Taylor K., Weichenthal M., Walewski J., Fisher D., McNeeley M., Gru A. A., Brown L., Palanca-Wessels M. C., Lisano J., Onsum M., Bunn V., Little M., Trepicchio W. L., Dummer R.

المساهمون: Kim Y.H., Prince H.M., Whittaker S., Horwitz S.M., Duvic M., Bechter O., Sanches J.A., Stadler R., Scarisbrick J., Quaglino P., Zinzani P.L., Wolter P., Eradat H., Pinter-Brown L.C., Ortiz-Romero P.L., Akilov O.E., Trotman J., Taylor K., Weichenthal M., Walewski J., Fisher D., McNeeley M., Gru A.A., Brown L., Palanca-Wessels M.C., Lisano J., Onsum M., Bunn V., Little M., Trepicchio W.L., Dummer R.

مصطلحات موضوعية: Antibody-drug conjugate, Brentuximab vedotin, CD30, Cutaneous T-cell lymphoma, Efficacy, Large-cell transformation, Mycosis fungoide, Objective response, Progression-free survival, Safety, Adult, Aged, 80 and over, Antineoplastic Agents, Immunological, Female, Follow-Up Studie, Human, International Agencie, Ki-1 Antigen, Male, Middle Aged, Physician, Prognosi, Retrospective Studie, Survival Rate, Young Adult, Choice Behavior, Decision Support Techniques

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33794441; info:eu-repo/semantics/altIdentifier/wos/WOS:000644993500008; volume:148; firstpage:411; lastpage:421; numberofpages:11; journal:EUROPEAN JOURNAL OF CANCER; https://hdl.handle.net/11585/866724Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85103377885; https://linkinghub.elsevier.com/retrieve/pii/S0959804921001180Test

الإتاحة: https://doi.org/10.1016Test/j.ejca.2021.01.054
https://hdl.handle.net/11585/866724Test
https://linkinghub.elsevier.com/retrieve/pii/S0959804921001180Test

المؤلفون: Horwitz S. M., Scarisbrick J. J., Dummer R., Whittaker S., Duvic M., Kim Y. H., Quaglino P., Zinzani P. L., Bechter O., Eradat H., Pinter-Brown L., Akilov O. E., Geskin L., Sanches J. A., Ortiz-Romero P. L., Weichenthal M., Fisher D. C., Walewski J., Trotman J., Taylor K., Dalle S., Stadler R., Lisano J., Bunn V., Little M., Miles Prince H.

المساهمون: Horwitz S.M., Scarisbrick J.J., Dummer R., Whittaker S., Duvic M., Kim Y.H., Quaglino P., Zinzani P.L., Bechter O., Eradat H., Pinter-Brown L., Akilov O.E., Geskin L., Sanches J.A., Ortiz-Romero P.L., Weichenthal M., Fisher D.C., Walewski J., Trotman J., Taylor K., Dalle S., Stadler R., Lisano J., Bunn V., Little M., Miles Prince H.

مصطلحات موضوعية: Adult, Brentuximab Vedotin, Human, Quality of Life, Lymphoma, T-Cell, Cutaneou, Physician, Skin Neoplasms

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34507350; info:eu-repo/semantics/altIdentifier/wos/WOS:000733368000011; volume:5; issue:23; firstpage:5098; lastpage:5106; numberofpages:9; journal:BLOOD ADVANCES; https://hdl.handle.net/11585/867056Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85121718931; https://ashpublications.org/bloodadvances/article/5/23/5098/476861/Randomized-phase-3-ALCANZA-study-of-brentuximabTest

الإتاحة: https://doi.org/10.1182/bloodadvances.2021004710Test
https://hdl.handle.net/11585/867056Test
https://ashpublications.org/bloodadvances/article/5/23/5098/476861/Randomized-phase-3-ALCANZA-study-of-brentuximabTest

المؤلفون: Straus D. J., Dlugosz-Danecka M., Alekseev S., Illes A., Picardi M., Lech-Maranda E., Feldman T., Smolewski P., Savage K. J., Bartlett N. L., Walewski J., Ramchandren R., Zinzani P. L., Hutchings M., Connors J. M., Radford J., Munoz J., Kim W. S., Advani R., Ansell S. M., Younes A., Miao H., Liu R., Fenton K., Forero-Torres A., Gallamini A.

المساهمون: Straus, D. J., Dlugosz-Danecka, M., Alekseev, S., Illes, A., Picardi, M., Lech-Maranda, E., Feldman, T., Smolewski, P., Savage, K. J., Bartlett, N. L., Walewski, J., Ramchandren, R., Zinzani, P. L., Hutchings, M., Connors, J. M., Radford, J., Munoz, J., Kim, W. S., Advani, R., Ansell, S. M., Younes, A., Miao, H., Liu, R., Fenton, K., Forero-Torres, A., Gallamini, A.

مصطلحات موضوعية: Clinical Trials and Observation, Lymphoid Neoplasia, Adult, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocol, Bleomycin, Brentuximab Vedotin, Dacarbazine, Doxorubicin, Female, Follow-Up Studie, Hodgkin Disease, Human, Intention to Treat Analysi, Male, Middle Aged, Neoplasm Staging, Survival Analysi, Treatment Outcome, Vinblastine

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000523314100008; volume:135; issue:10; firstpage:735; lastpage:742; numberofpages:8; journal:BLOOD; http://hdl.handle.net/11588/823875Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85081944235

الإتاحة: https://doi.org/10.1182/BLOOD.2019003127Test
http://hdl.handle.net/11588/823875Test

المؤلفون: Straus D., Collins G., Walewski J., Zinzani P. L., Grigg A., Sureda A., Illes A., Kim T. M., Alekseev S., Specht L., Buccheri V., Younes A., Connors J., Forero-Torres A., Fenton K., Gautam A., Purevjal I., Liu R., Gallamini A.

المساهمون: Straus D., Collins G., Walewski J., Zinzani P.L., Grigg A., Sureda A., Illes A., Kim T.M., Alekseev S., Specht L., Buccheri V., Younes A., Connors J., Forero-Torres A., Fenton K., Gautam A., Purevjal I., Liu R., Gallamini A.

مصطلحات موضوعية: brentuximab vedotin, frontline therapy, growth factor, Hodgkin lymphoma, primary prophylaxis

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000562603900001; volume:61; issue:12; firstpage:2931; lastpage:2938; numberofpages:8; journal:LEUKEMIA & LYMPHOMA; https://hdl.handle.net/11585/805688Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85089869516

الإتاحة: https://doi.org/10.1080/10428194.2020.1791846Test
https://hdl.handle.net/11585/805688Test